Tim Waterboer (Germany)
German Cancer Research Center (DKFZ) Infections and Cancer Epidemiology
Presenter of 1 Presentation
EARLY DETECTION OF HPV-DRIVEN OROPHARYNGEAL CANCER USING HPV SEROLOGY IN THE STUDY OF PREVENTION OF ANAL CANCER (ID 1092)
Session Time
14:15 - 15:15
Session Type
Public Health Oral Session
Lecture Time
14:51 - 15:03
Moderator of 1 Session
Session Type
Clinical Science Oral Session
Session Time
07:30 - 08:10
[{"name":"SPATIAL PROXIMITY BETWEEN T AND PD-L1 EXPRESSING CELLS AS A PROGNOSTIC BIOMARKER FOR OROPHARYNGEAL SQUAMOUS CELL CARCINOMA \u003Csmall\u003E(ID 314)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":314,"presentation":"SPATIAL PROXIMITY BETWEEN T AND PD-L1 EXPRESSING CELLS AS A PROGNOSTIC BIOMARKER FOR OROPHARYNGEAL SQUAMOUS CELL CARCINOMA \u003Csmall\u003E(ID 314)\u003C\/small\u003E","session":"Oral Session 7: Oropharyngeal Cancer - Biomarkers for Diagnosis and Prognosis","presenter":"Peter L. Stern (United Kingdom)","photo":""},"playlist":[{"name":"SPATIAL PROXIMITY BETWEEN T AND PD-L1 EXPRESSING CELLS AS A PROGNOSTIC BIOMARKER FOR OROPHARYNGEAL S","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/78\/P314_S_960_Updated.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/78\/P314_S_960_Updated.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/78\/BF99522.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/78\/P314_S_960_Updated.vtt"}]},{"name":"THE HPV SEROLOGY STANDARDIZATION INITIATIVE: AIMS AND PROGRESS TO DATE AT THE FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH \u003Csmall\u003E(ID 814)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":814,"presentation":"THE HPV SEROLOGY STANDARDIZATION INITIATIVE: AIMS AND PROGRESS TO DATE AT THE FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH \u003Csmall\u003E(ID 814)\u003C\/small\u003E","session":"Oral Session 7: Oropharyngeal Cancer - Biomarkers for Diagnosis and Prognosis","presenter":"Ligia A. Pinto (United States of America)","photo":""},"playlist":[{"name":"THE HPV SEROLOGY STANDARDIZATION INITIATIVE AIMS AND PROGRESS TO DATE AT THE FREDERICK NATIONAL LABO","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/78\/Ligia Pinto IPVC20 814 THE HPV SEROLOGY STANDARDIZATION INITIATIVE AIMS AND PROGRESS TO DATE AT THE FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/78\/Ligia Pinto IPVC20 814 THE HPV SEROLOGY STANDARDIZATION INITIATIVE AIMS AND PROGRESS TO DATE AT THE FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/78\/19360B26.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/78\/Ligia Pinto IPVC20 814 THE HPV SEROLOGY STANDARDIZATION INITIATIVE AIMS AND PROGRESS TO DATE AT THE FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH.vtt"}]}]
{"type":2,"code":"6E32UU02m"}
[session]
[presentation]
[presenter]